These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14666454)

  • 1. Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
    Hiyama E; Hiyama K; Nishiyama M; Reynolds CP; Shay JW; Yokoyama T
    J Pediatr Surg; 2003 Dec; 38(12):1730-4. PubMed ID: 14666454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of favorable and unfavorable neuroblastomas.
    Hiyama E; Hiyama K; Yamaoka H; Sueda T; Reynolds CP; Yokoyama T
    Pediatr Surg Int; 2004 Jan; 20(1):33-8. PubMed ID: 14691637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity as a prognostic factor in neuroblastomas.
    Streutker CJ; Thorner P; Fabricius N; Weitzman S; Zielenska M
    Pediatr Dev Pathol; 2001; 4(1):62-7. PubMed ID: 11200492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
    Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
    Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
    Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.
    Samy M; Gattolliat CH; Pendino F; Hillion J; Nguyen E; Bombard S; Douc-Rasy S; Bénard J; Ségal-Bendirdjian E
    Mol Cancer Ther; 2012 Nov; 11(11):2384-93. PubMed ID: 22933702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments.
    Kawashima M; Kojima M; Ueda Y; Kurihara S; Hiyama E
    J Pediatr Surg; 2016 Dec; 51(12):2080-2085. PubMed ID: 27793328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Ichikawa T; Shay JW; Yokoyama T
    Eur J Cancer; 1997 Oct; 33(12):1932-6. PubMed ID: 9516827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
    Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
    Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
    Poremba C; Scheel C; Hero B; Christiansen H; Schaefer KL; Nakayama Ji; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    J Clin Oncol; 2000 Jul; 18(13):2582-92. PubMed ID: 10893290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma.
    Wang SL; Chen WT; Li SH; Li SW; Yang SF; Chai CY
    APMIS; 2007 Jan; 115(1):17-21. PubMed ID: 17223847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.
    Poremba C; Hero B; Heine B; Scheel C; Schaefer KL; Christiansen H; Berthold F; Kneif S; Stein H; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2000 Dec; 35(6):651-5. PubMed ID: 11107139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.
    Coco S; Theissen J; Scaruffi P; Stigliani S; Moretti S; Oberthuer A; Valdora F; Fischer M; Gallo F; Hero B; Bonassi S; Berthold F; Tonini GP
    Int J Cancer; 2012 Oct; 131(7):1591-600. PubMed ID: 22234802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
    Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y
    Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating telomerase activity levels with human neuroblastoma outcomes.
    Hiyama E; Hiyama K; Yokoyama T; Matsuura Y; Piatyszek MA; Shay JW
    Nat Med; 1995 Mar; 1(3):249-55. PubMed ID: 7585042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genes identified by microarray analysis in favorable neuroblastoma.
    Kamei N; Hiyama K; Yamaoka H; Kamimatsuse A; Onitake Y; Sueda T; Hiyama E
    Pediatr Surg Int; 2009 Nov; 25(11):931-7. PubMed ID: 19701758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
    Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
    Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.